Two anti-inflammatory drugs for rheumatoid arthritis work better together than either does individually, researchers report in the Feb. 28 Lancet.
The scientists randomly assigned one-third of 682 arthritis sufferers to receive methotrexate pills, a frontline arthritis drug, plus twice-weekly injections of the drug etanercept. The other volunteers received either methotrexate plus an inert shot, or etanercept shots in combination with inert pills.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.